Dr Bernd Seizinger
Independent Director
Fountain health care
Ireland
Biography
President and Chief Executive Officer of GPC Biotech (Munich, Germany and Princeton, NJ, USA) from 1998-2009 Is a board member of three other biotechnology companies Previously Vice President of Oncology Drug Discovery and - in parallel - Vice President of Corporate and Academic Alliances at Bristol-Myers Squibb
Research Interest
Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways